MARC Record from marc_columbia

LEADER: 14467pam a22004694a 4500
001 5908265
005 20221121210817.0
008 060609s2006 maua b 101 0 eng
010 $a 2006019005
016 7 $a101278777$2DNLM
020 $a1573315974 (alk. paper)
024 3 $a9781573315975
035 $a(OCoLC)ocm70119700
035 $a(NNC)5908265
035 $a5908265
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dBAKER$dOrLoB-B
042 $apcc
050 00 $aRC280.A3$bP4554 2006
060 00 $aW1$bAN626YL v.1073 2006
060 10 $aQZ 380$bP5405 2006
082 00 $a616.99/445$222
245 00 $aPheochromocytoma :$bfirst international symposium /$cedited by Karel Pacak and Graeme Eisenhofer.
260 $aBoston, Mass. :$bPublished by Blackwell Pub. on behalf of the New York Academy of Sciences,$c2006.
300 $axvi, 588 pages :$billustrations ;$c23 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAnnals of the New York Academy of Sciences,$x0077-8923 ;$vv. 1073
504 $aIncludes bibliographical references and index.
505 00 $tAn overview of pheochromocytoma : history, current concepts, vagaries, and diagnostic challenges /$rWilliam M. Manger -- $tParagangliomas : clinical overview /$rWilliam F. Young, Jr. -- $tCharacteristics of pheochromocytoma in a 4- to 20-year-old population /$rMarta Barontini, Gloria Levin and Gabriela Sanso -- $t1,111 patients with adrenal incidentalomas observed at a single endocrinological center : incidence of chromaffin tumors /$rAnna A. Kasperlik-Zaluska, Elzbieta Roslonowska, Jadwiga Slowsinska-Srzednicka, Maciej Otto, Andrzej Cichocki, Jaroslaw Cwikla, Rafal Slapa and Graeme Eisenhofer -- $tLack of symptoms in patients with histologic evidence of pheochromocytoma : a diagnostic challenge /$rDebbie L. Cohen, Gouglas Fraker and Raymond R. Townsend -- $tA case of catecholamine and glucocorticoid excess syndrome due to a corticotropin-secreting paraganglioma /$rHolger S. Willenberg, Joachim Feldkamp, Reiner Lehmann, Matthias Schott, Peter E. Goretzki and Werner A. Scherbaum -- $tCatecholamine-secreting metastatic carcinoid as differential diagnosis in pheochromocytoma : clinical, laboratory, and imaging clues in the search for the lurking neuroendocrine tumor (NET) /$rHendricks H. Whitman III, Elliot K. Fishman, Kjell Oberg, Joseph M. Wildman and Andrea L. Long -- $tCatecholamine excretion and circadian blood pressure profile in patients with pheochromocytoma /$rElzbieta D. Dabrowska, Jacek Lewandowski, Piotr Jedrusik, Bartosz Symonides, Bozena Wocial, Mariusz Lapinski and Zbigniew Gaciong -- $tCharacteristics of blood pressure in pheochromocytoma /$rTomas Zelinka, Karel Pacak and Jiri Wldimsky, Jr. -- $tGenetic testing in pheochromocytoma : increasing importance for clinical decision making /$rStefan R. Bornstein and Anne-Paule Gimenez-Roqueplo -- $tGenetic testing pheochromocytoma-and paraganglioma-associated syndromes /$rDiana E. Benn, Anne Louise Richardson, Deborah J. Marsha and Bruce G. Robinson -- $tNew advances in the genetics of pheochromocytoma and paraganglioma syndromes /$rAnne-Paule Gimenz-Roqueplo -- $tGenetic and clinical investigation of pheochromocytoma : a 22-year experience, from Freiburg, Germany to international effort /$rBirke Bausch, Carsten C. Boedeker, Ansgar Berlis, Ingo Brink, Markus Cybulla, Martin K. Walz, AndrzejJanuszewicz, Claudio Letizia, Giuseppe Opocher, Charis Eng and Hartmut P. H. Neumann -- $tGenetic analysis of apparently sporadic pheochromocytomas : the Rotterdam experience /$rE. Korpershoek, F. H. Van Nederveen, H. Dannenberg, B. J. Petri, P. Komminoth, A. Perren, J. W. Lenders, A. A. Verhofstad, W. W. De Herder, R. R. De Krijger and W. N. Dinjens -- $tFamilial nonsyndromic pheochromocytoma /$rGiuseppe Opocher, Francesca Schiavi, Maurizio Iacobone, Antonio Toniato, Sabina Sattarova, Zoran Erlic, Maddalena Martella, Caterina Mian, Isabella Merante Boschin, Laura Zamboni, Paola De Lazzari, Alessandra Murgia, Maria Rosa Pelizzo, Gennaro Favia and Franco Mantero -- $tGenetic mutation screening in an Italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients /$rM. Castellano, L. Mori, M. Giacche, E. Agliozzo, R. Tosni, A. Panarotto, C. Cappelli, P. Mulatero, D. Cumetti, F. Veglio and E. Agabiti-Rosei -- $tFrequent genetic changes in childhood pheochromocytomas /$rRonald R. De Krijger, Francien H. Van Nederveen, Esther Korpershoek, Wouter W. De Herder, Sabine M. P. F. De Muinck Keizer-Schrama and Winant N. M. Dinjens -- $tThe occurrence of SDHB gene mutations in pheochromocytoma /$rFrancien H. Van Nedereen, Winant N. M. Dinjens, Esther Korpershoek and Ronald R. De Krijger -- $tSDH mutations in patients affected by paraganglioma syndromes : a personal experience /$rM. Mannelli, L. Simi, T. Ercolino, M. S. Gagliano, L. Becherini, S. Vinci, R. Sestini, F. Gensini, P. Pinzani, M. Mascalchi, L. Guerrini, C. Pratesi, G. Nesi, F. Torti, F. Cipollini, G. P. Bernin and M. Genuardi -- $tParaganglioma syndrome : SDHB, SDHC, and SDHD mutations in head and neck paragangliomas /$rFrancesca Schiavi, Theodoros Savvoukidis, Franco Trabalzini, Franco Grego, Michele Piazza, Pietro Amista, Serena Dematte, Antonella Del Piano, Maria Enrica Cecchini, Zoran Erlic, Paola De Lazzari, Franco Mantero and Giuseppe Opocher -- $tGermline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndrome /$rLibero Santarpia, Daniela Lapa and Salvatore Benvenga -- $tVon Hippel-Lindau gene mutation in non-syndromic familial pheochromocytomas /$rAn-Li Tong, Zheng-Pei Zeng, Han-Zhong Li, Di Yang, Lin Lu, Ming Li, Ya-Ru Zhou, Jing Zhang, Shi Chen and Wei Liang -- $tTranscription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas /$rPatricia L. M. Dahia -- $tA phenotypic perspective on mammalian oxygen sensor candidates /$rBora E. Baysal -- $tMolecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2 /$rTaranjit S. Gujral and Lois M. Mulligan -- $tTranscription regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 /$rThanh-Truc Huynh Karel Pacak, Dona L. Wong, W. Marston Linehan, David S. Goldstein, Abdel G. Elkahloun, Peter J. Munson and Graeme Eisenhofer -- $tExpression of mRNAs for succinate dehydrogenase subunits and related genes in pheochromocytoma /$rKazumasa Isobe, Sumiko Nissato, Ichiro Tatsuno, Toru Yashiro, Kazuhiro Takekoshi and Yasushi Kawakami -- $tThe norepinephrine transporter and pheochromocytoma /$rSusannah Cleary and Jacqueline K. Phillips -- $tExpression and effect of adrenomedullin in pheochromocytoma /$rZheng-Pei Zeng, Dong-Mei Liu, Han-Zhong Li, Xin-Rong Fan, Guo-Qiang Liu, Wei-Gang Yan, An-Li Tong and Xin Zheng -- $tExpression and effect of transforming growth factor-[alpha] and tumor necrosis factor-[alpha] in human pheochromocytoma /$rAn-Li Tong, Zheng-Pei Zeng, Han-Zhong Li, Di Yang, Lin Lu and Ming Li -- $tThe effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues /$rZheng-Pei Zeng, Guo-Qiang Liu, Han-Zhang Li, Xin-Rong Fan, Dong-Mei Liu, An-Li Tong, Xin Zheng and Chang Liu -- $tGene expression profiling of rat pheochromocytoma /$rAbdel G. Elkahloun, James F. Powers, Abraham Nyska, Graeme Eisenhofer and Arthur S. Tischler -- $tAnimal models of pheochromocytoma including NIH initial experience /$rShoichiro Ohta, Edwing W. Lai, Shun'Ichiro Taniguchi, Arthur S. Tischler, Salvatore Alesci and Karel Pacak -- $tDHEA reduces NGF-mediated cell survival in serum-deprived PC12 cells /$rChristian G. Ziegler, Flavie Sicard, Simone Sperber, Monika Ehrhart-Bornstein, Stefan R. Bornstein and Alexander W. Krug -- $tRole of DHEA and growth factors in chromaffin cell proliferation /$rF. Sicard, A. W. Krug, C. G. Ziegler, S. Sperberg, M. Ehrhart-Bornstein and S. R. Bornstein -- $tAnalysis of PTEN mutation in non-familial pheochromocytoma /$rJanusz Puc, Grzegorz Placha, Bozenna Wocial, Katrina Podsypanina, Ramon Parsons and Zbigniew Gaciong -- $tBiochemical diagnosis and localization of pheochromocytoma : can we reach a consensus? /$rAshley Grossman, Karel Pacak, Anna Sawka, Jacques W. M. Lenders, Debra Harlander, Robert T. Peaston, Rodney Reznek, James Sisson and Graeme Eisenhofer -- $tDiagnostic value of biochemical parameters in the differential diagnosis of an adrenal mass /$rStephan Petersenn, Nicole Unger, Martin K. Walz and Klaus Mann -- $tMulticenter study on the diagnostic value of a new RIA for the detection of free plasma metanephrines in the work-up for pheochromocytoma /$rTomas Lenz, Joachim Zorner, Carl Kirchmaier, Daniele Pillitteri, Klaus Badenhoop, Christine Bartel, Helmut Geiger, Katrin Hasselbacher, Ulrich Tuschy, Jurgen Westermann and Lothar Salewski -- $tCurrent trends in functional imaging of pheochromocytomas and paragangliomas /$rBarry L. Shulkin, Ioannis Ilias, James C. Sisson and Karel Pacak --
505 80 $tChanges in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas /$rLaurence Amar, Severine Peyrard, Patrick Rossignol, Franck Zinzindohoue, Anne-Paule Gimenez-Roqueplo and Pierre-Francois Plouin -- $tAnatomical and functional imaging of tumors in animal models : focus on pheochromocytoma /$rLucia Martiniova, Shoichiro Ohta, Peter Guion, Daniel Schmimel, Edwin W. Lai, Brenda Klaunberg, Elaine Jagoda and Karen Pacak -- $tManagement and treatment of pheochromocytomas and paragangliomas /$rMassimo Mannelli -- $tRisk-oriented approach to hereditary adrenal pheochromocytoma /$rAndreas Machens, Michael Brauckhoff, Oliver Gimm and Henning Dralle -- $tTreatment of bilateral pheochromocytoma and adrenal medullary hyperplasia /$rSvante Jansson, Amir Khorram-Manesh, Ola Nilsson, Lars Kolby, Lars-Erik Tisell, Bo Wangberg and Hakan Ahlman -- $tAT[subscript 2] receptor stimulation may halt progression of pheochromocytoma /$rMorris J. Brown, Isla S. Mackenzie, Michael J. Ashby, Kottekkattu K. Balan and Derek S. Appleton -- $tMortality associated with pheochromocytoma : increased risk for additional tumors /$rAmir Khorram-Manesh, Svante Jansson, Bo Wangeberg, Ola Nilsson, Lars-Erik Tisell and Hakan Ahlman -- $tMalignant pheochromocytoma : state of the field with future projections /$rHakan Ahlman -- $tMalignant pheochromocytomas and paragangliomas : a phase II study of therapy with high-dose [superscript 131]I-metaiodobenzylguanidine ([superscript 131]I-MIBG) /$rPaul A. Fitzgerald, Robert E. Goldsby, John P. Huberty, David C. Price, Randall A. Hawkins, Janet J. Veatch, Filemon Dela Cruz, Thierry M. Jahan, Charles A. Linker, Lloyd Damon and Katherine K. Matthay -- $tCan quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas? /$rLars Kolby, Peter Bernhardt, Viktor Johanson, Bo Wangberg, Andreas Muth, Svante Jansson, Eva Forssell-Aronsson, Ola Nilsson and Hakan Ahlman -- $tAspects on radionuclide therapy in malignant pheochromocytomas /$rEva Forssell-Aronsson, Peter Bernhardt, Bo Wangberg, Lars Kolby, Ola Nilsson and Hakan Ahlman -- $tCourses of malignant pheochromocytoma : implications for therapy /$rJames C. Sisson, Barry L. Shulkin and Nazanene H. Esfandiari -- $tMalignant pheochromocytoma in a population-based study : survival and clinical results /$rBo Wangberg, Andreas Muth, Amir Khorram-Manesh, Svante Jansson, Ola Nilsson, Eva Forssell-Aronsson, Larserik Tisell and Hakan Ahlman -- $tDoes the expression of c-kit (CD117) in neuroendocrine tumors represent a target for therapy? /$rChristian A. Koch, Oliver Gimm, Alexander O. Vortmeyer, Haifa K. Al-Ali, Peter Lamesch, Rudolf Ott, Regine Kluge, Uta Bierbach and Andrea Tannapfel -- $tExpression and processing of the neuroendocrine protein secretogranin II in benign and malignant pheochromocytomas /$rJohann Guillemot, Laure Barbier, Erwan Thouennon, Virginie Vallet-Erdtmann, Maite Montero-Hadiadje, Herve Lefebvre, Marc Klein, Mihaela Muresan, Pierre-Francois Plouin, Nabil Seidah, Hubert Vaudry, Youssef Anouar and Laurent Yon -- $tDevelopment of novel tools for the diagnosis and prognosis of pheochromocytoma using peptide marker immunoassay and gene expression profiling approaches /$rYoussef Anouar, Laurent Yon, Johann Guillemot, Erwan Thouennon, Laure Barbier, Anne-Paule Gimenez-Roqueplo, Jerome Bertherat, Herve Lefebvre, Marc Klein, Mihaela Muresan, Eric Grouzmann, Pierre-Francois Plouin, Hubert Vaudry and Abdel G. Elkahloun -- $tGene expression profiling of benign and malignant pheochromocytoma /$rFrederieke M. Brouwers, Abdel G. Elkahloun, Peter J. Munson, Graheme Eisenhofer, Jennifer Barb, W. Marston Linehan, Jacques W. M. Lenders, Ronald De Krijger, Massimo Mannelli, Robert Udelsman, Idris T. Ocal, Barry L. Shulkin, Stefan R. Bornstein, Jan Breza, Lucia Ksinantova and Karel Pacak -- $tPathology of pheochromocytoma and extra-adrenal paraganglioma /$rArthur S. Tischler, Noriko Kimura and Anne Marie McNicol -- $tDistinct expression of galectin-3 in pheochromocytomas /$rOliver Gimm, Ulf Krause, Michael Brauckhoff, Cuong Hoang-Vu and Henning Dralle -- $tExpression of connexins in chromaffin cells of normal human adrenals and in benign and malignant pheochromocytomas /$rHolger S. Willenberg, Matthias Schott, Wolfgang Saeger, Annette Tries, Werner A. Scherbaum and Stefan R. Bornstein.
650 0 $aPheochromocytoma$vCongresses.
650 12 $aPheochromocytoma$xdiagnosis.$0https://id.nlm.nih.gov/mesh/D010673Q000175
650 12 $aPheochromocytoma$xgenetics.$0https://id.nlm.nih.gov/mesh/D010673Q000235
650 22 $aDiagnosis, Differential.$0https://id.nlm.nih.gov/mesh/D003937
650 22 $aPheochromocytoma$xtherapy.$0https://id.nlm.nih.gov/mesh/D010673Q000628
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aPacak, Karel.$0http://id.loc.gov/authorities/names/n2002135583
700 1 $aEisenhofer, Graeme.$0http://id.loc.gov/authorities/names/n00003736
710 2 $aNew York Academy of Sciences.$0http://id.loc.gov/authorities/names/n79032973
830 0 $aAnnals of the New York Academy of Sciences ;$vv. 1073.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0615/2006019005.html
852 00 $boff,sci$hQ11$i.N42 v.1073